In contrast, another study observed that targeting GSK3β by RNAi or pharmacological inhibitors resulted in p53-dependent induction of p21 and apoptosis in colorectal cancer cells harboring wild-type p53, thereby inhibiting tumor growth in xenograft mice models [123]. Here, TP53 is linked to neoplasm.